Clinuvel Pharmaceuticals buy dokem
Start price
30.09.16
/
50%
€4.35
Target price
30.03.17
€9.50
Performance (%)
15.31%
End price
30.03.17
€5.02
Summary
This prediction ended on 30.03.17 with a price of €5.02. The BUY prediction by dokem finished with a performance of 15.31%. dokem has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Clinuvel Pharmaceuticals | -3.607% | -3.607% | -21.137% | -49.779% |
iShares Core DAX® | 1.280% | 1.320% | 13.605% | 15.782% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% | 38.434% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% | 6.570% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% | 39.611% |
Comments by dokem for this prediction
In the thread Clinuvel Pharmaceuticals diskutieren
dokem stimmt der Buy-Einschätzung von ValueFox zu
dokem stimmt am 30.09.2016 der Buy-Einschätzung von ValueFox mit dem Kursziel 12,6€ zu.Überschrift: Clinuvel: "strong buy" nach erfolgreichem Markteintritt
(Laufzeit überschritten)